Topical roflumilast formulation having improved delivery and plasma half-life | Patent Number 12005052
US 12005052 B2Filled DateJul 17, 2023
Priority DateJun 7, 2017
Publication DateNov 16, 2023
Expiration DateJun 6, 2037
Inventor/ApplicantsDavid W. OSBORNE
David W. Osborne
David W. Osborne
ExaminesHOWELL, THEODORE R.
Art Unit1628
Technology Center1600
Law Firm
You must be logged in to view
LoginAttorneys
Subscription-Only
View Concierge ProgramEmpower your practice with Patexia Publication Prosecution IP Module.
Get access to our exclusive rankings and unlock powerful data.
Looking for a Publication Attorney?
Get in touch with our team or create your account to start exploring a
network of over 120K attorneys.